Mito Blue C (MBC) has been used safely by humans for over 100 years. The most significant benefit of Mito Blue C [MBC] is its ability to restore a dysfunctional mitochondrion. Our mitochondria are the “motor” and “brains” in our cells.
Studies show that once we reach the age of 70, only an average of 15% of the mitochondria is working correctly; no wonder older people feel so tired. Mito Blue C boosts mitochondrial energy, is anti-ageing, and improves mood and memory. [1,2]
It also improves circulation and helps fight fatigue. When a person suffers from any health problem, the mitochondria is malfunctioning. So, correcting and restoring the mitochondria is truly the “holy grail” of resolving many health concerns.
Perhaps the most well-known role of mitochondria is the production of ATP, the energy currency of cells. When the mitochondria are defective, the cells do not have enough energy. The unused oxygen and fuel molecules build up in the cells and cause damage.
Our MBC is water- and fat-soluble, enabling it to enter right into the mitochondria of the cells and even pass the “blood-brain barrier”.
The first therapeutic use for MBC was as a treatment against malaria. Recent research has shown that it may be neuroprotective against several cytotoxicity related to many common diseases, such as stroke (leading to a heart attack) and Parkinson’s disease. MBC can prevent and manage brain damage in relation to tumours, likely due to its role in the oxidation of NADH and restoration of mitochondrial enzymes.
Our brain’s neurons rely almost entirely on mitochondria-derived energy.  Failure of mitochondrial function can affect the rest of your body. But it’s particularly detrimental to your brain. This is where Mito Blue C really shines as possibly one of the most essential anti-ageing and neurological disease-preventing nootropics (cognitive enhancers) we have available today.
Store at room temperature, away from light and moisture. Do not store it in the bathroom. Keep all medicines away from children and pets.
Ramsay, R. R., Dunford, C., & Gillman, P. K. (2007). Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction. British Journal of Pharmacology, 152(6), 946–951. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2078225/